436 related articles for article (PubMed ID: 8428341)
1. Recessive oncogenes.
Bookstein R; Allred DC
Cancer; 1993 Feb; 71(3 Suppl):1179-86. PubMed ID: 8428341
[TBL] [Abstract][Full Text] [Related]
2. Suppressor genes in breast cancer: an overview.
Steeg PS
Cancer Treat Res; 1992; 61():45-57. PubMed ID: 1360244
[TBL] [Abstract][Full Text] [Related]
3. Genetic studies and molecular markers of bladder cancer.
Cordon-Cardo C; Sheinfeld J; Dalbagni G
Semin Surg Oncol; 1997; 13(5):319-27. PubMed ID: 9259087
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor genes in prostatic oncogenesis.
Bookstein R
J Cell Biochem Suppl; 1994; 19():217-23. PubMed ID: 7823594
[TBL] [Abstract][Full Text] [Related]
5. Tumour-suppressor genes in prostatic oncogenesis: a positional approach.
Bookstein R; Bova GS; MacGrogan D; Levy A; Isaacs WB
Br J Urol; 1997 Mar; 79 Suppl 1():28-36. PubMed ID: 9088270
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma and p53 genes as prognostic indicators in urological oncology.
Wolff JM; Stephenson RN; Jakse G; Habib FK
Urol Int; 1994; 53(1):1-5. PubMed ID: 7974878
[TBL] [Abstract][Full Text] [Related]
7. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressor genes: a new era for molecular genetic studies of cancer.
Lee EY
Breast Cancer Res Treat; 1991 Sep; 19(1):3-13. PubMed ID: 1756264
[TBL] [Abstract][Full Text] [Related]
9. Oncogenes and antioncogenes in lung tumorigenesis.
Giaccone G
Chest; 1996 May; 109(5 Suppl):130S-134S. PubMed ID: 8635391
[TBL] [Abstract][Full Text] [Related]
10. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor gene allelic loss in human renal cancers.
Brooks JD; Bova GS; Marshall FF; Isaacs WB
J Urol; 1993 Oct; 150(4):1278-83. PubMed ID: 8371415
[TBL] [Abstract][Full Text] [Related]
12. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
13. Activated oncogenes and putative tumor suppressor genes involved in human breast cancers.
Tripathy D; Benz CC
Cancer Treat Res; 1992; 63():15-60. PubMed ID: 1363356
[TBL] [Abstract][Full Text] [Related]
14. Genetic changes in prostate cancer.
Konishi N; Cho M; Yamamoto K; Hiasa Y
Pathol Int; 1997 Nov; 47(11):735-47. PubMed ID: 9413032
[TBL] [Abstract][Full Text] [Related]
15. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
16. [Cell cycle, tumor suppressor genes and lung cancers].
Bréchot JM
Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
[TBL] [Abstract][Full Text] [Related]
17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Savitskaja TV; Bydanov OI; Belevtsev MV; Potapnev MP
Leuk Res; 2005 Nov; 29(11):1271-6. PubMed ID: 15878620
[TBL] [Abstract][Full Text] [Related]
19. [Mechanisms for inactivation of tumor suppressor genes].
Ishizaki K
Nihon Rinsho; 1995 Nov; 53(11):2660-5. PubMed ID: 8538022
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in prostate cancer.
Isaacs WB; Bova GS; Morton RA; Bussemakers MJ; Brooks JD; Ewing CM
Cold Spring Harb Symp Quant Biol; 1994; 59():653-9. PubMed ID: 7587126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
